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Tic disorders are moderately heritable common psychiatric disorders that can be highly troubling, both
in childhood and in adulthood. In this study, we report results obtained in the first epigenome-wide
association study (EWAS) of tic disorders. The subjects are participants in surveys at the Netherlands Twin
Register (NTR) and the NTR biobank project. Tic disorders were measured with a self-report version of
the Yale Global Tic Severity Scale Abbreviated version (YGTSS-ABBR), included in the 8th wave NTR data
collection (2008). DNA methylation data consisted of 411,169 autosomal methylation sites assessed by the
Illumina Infinium HumanMethylation450 BeadChip Kit (HM450k array). Phenotype and DNA methylation
data were available in 1,678 subjects (mean age = 41.5). No probes reached genome-wide significance
(p < 1.2 × 10−7). The strongest associated probe was cg15583738, located in an intergenic region on
chromosome 8 (p = 1.98 × 10−6). Several of the top ranking probes (p < 1 × 10−4) were in or nearby
genes previously associated with neurological disorders (e.g., GABBRI, BLM, and ADAM10), warranting
their further investigation in relation to tic disorders. The top significantly enriched gene ontology (GO)
terms among higher ranking methylation sites included anatomical structure morphogenesis (GO:0009653,
p = 4.6 × 10−15) developmental process (GO:0032502, p = 2.96 × 10−12), and cellular developmental
process (GO:0048869, p = 1.96 × 10−12). Overall, these results provide a first insight into the epigenetic
mechanisms of tic disorders. This first study assesses the role of DNAmethylation in tic disorders, and it lays
the foundations for future work aiming to unravel the biological mechanisms underlying the architecture
of this disorder.
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Tic disorders form a broad spectrum encompassing four
different clinical entities: Tourette syndrome (TS), chronic
(motor or vocal) tic disorder, transient tic disorder, and
tic disorder not otherwise specified. Tics are characterized
by sudden, rapid, motor movements, or vocalizations, per-
formed in a ritualized, recurrent, and stereotypical fashion
(DSM-IV-TR; American Psychiatric Association, 2000).
Multiple lines of evidence suggest that both genetic and
interacting environmental factors are causes underlying the
etiology of these phenotypes (Paschou, 2013). Twin and
family studies have shown that the prevalence of TS or
chronic tic disorders among first-degree relatives of af-
fected individuals varies between 15% and 53% (Towbin,
2010). Furthermore, heritability estimates on tic disorders
or TS range between 0.28 and 0.56 (Anckarsa¨ter et al., 2011;
Bolton et al., 2007; de Haan et al., 2015; Lichtenstein et al.,
2010;Mathews&Grados, 2011;Ooki, 2005).However,most
genetic and clinical studies so far have been hampered by
small sample sizes, ambiguity in phenotype definitions, and
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TABLE 1
Number of Participants Included in the Analysis
MZ twins DZ/DOS twins Relatives
Male (case/control) Female (case/control) Male (case/control) Female (case/control) Male (case/control) Female (case/control)
N 241 (30/211) 680 (74/606) 213 (31/182) 404 (38/366) 63 (8/55) 77 (7/70)
Age (SE) 42.48 (14.00) 40.57 (12.08) 37.61(10.11) 38.46 (11.04) 42.83 (14.10) 41.96 (12.45)
Note: MZ = monozygotic twins, DZ = dizygotic twins, DOS = dizygotic opposite-sex twins.
difficulties in disentangling genetic and familial environ-
mental effects. Thus, molecular genetic studies have thus
far not yet yielded robust findings (Pauls et al., 2014).
The study of epigenetic mechanisms on a genome-wide
scale in humans represents the bridge between disease sus-
ceptibility and gene expression variation. It is known that
epigenetic mechanisms regulate gene expression, and that
these epigenetic mechanisms change during life, up- and
down-regulating different genes in response to external en-
vironmental conditions. DNA methylation at CpG dinu-
cleotides is the most studied epigenetic mechanism in hu-
mans. It regulates gene expression by targeting, for example,
promoters and enhancers, and its pattern may change as a
consequence of external and internal stimuli (Hackett et al.,
2013). DNA methylation is also involved in other biologi-
cal processes such as genomic imprinting, where CpG sites
are methylated based on their parental origin, which are
different between the paternal and maternal branch (Liu
et al., 2010), and chromosome X inactivation, where one
copy of the female X chromosome is inactivated (Heard
et al., 1997). Genomic imprinting has also been suggested
to be involved in TS in a study evaluating parental gender-
influenced differences in childhood TS phenotype. Greater
motor tic complexity was associated with maternal trans-
mission, whereas higher frequency in vocal tics was associ-
ated with paternal transmission (Lichter et al., 1995).
EWAS have thus far been used to reveal altered methyla-
tion patterns in several complex disorders such as obesity,
diabetes, schizophrenia, and autism (Dempster et al., 2011;
Moore et al., 2014;Rakyan et al., 2011;Wockner et al., 2014).
This approach is becoming increasingly accessible and it is
likely that DNA methylation is also involved in other neu-
rological disorders. Currently, no EWAS of tic disorders
have been performed. These studies may clarify underlying
mechanisms that differentially regulate genes in individuals
manifesting tics.
Here, we report on the first EWAS of tic disorders per-
formed in a population-based sample from the NTR.
Material and Methods
Subjects’ Demographics
Subjects in this study are participants in the NTR biobank
Project (Willemsen et al., 2010, 2013). Since 1991, the NTR
has been collecting information on a broad range of pheno-
types in twins and familymembers (Willemsen et al., 2013).
In total, 3,264 peripheral blood samples from 3,221 NTR
participants have been assessed for genome-wide methyla-
tion data. After quality control (QC) on the methylation
data, the total final selection comprised 3,089 samples, for
a total of 3,057 individuals (32 subjects had methylation
data for two time points). For a complete description of the
entire methylation dataset from the NTR, please see Van
Dongen et al. (2015).
In the present study, we analyzed tic data from the 2008
wave of collection in a subset of individuals in whom
genome-wide methylation data were available. A total of
1,678 individuals (twins, siblings, and parents) from 1,057
families were included in the analysis. Table 1 gives an
overview of the subjects entered in the analysis and demo-
graphics. Zygosity was assessed by DNA polymorphisms as
described by van Beijsterveldt et al. (2013). The study was
approved by the Central Ethics Committee on Research in-
volving human subjects of the VU University Amsterdam.
Phenotype
Tics were measured using an abbreviated 12-item self-
report versionof theYGTSS, the latter being awell-validated
interview with a high internal consistency (Cronbach’s al-
pha > 0.90; Leckman et al., 1989). The YGTSS-abbreviated
(YGTSS-ABBR) contains the 12 most frequently occurring
tics, assessing their occurrence: never (0), < than 1 year ago
(1), between 15 years ago (2) or as a child (3). Three addi-
tional questions are asked on age at onset, duration, and
severity, to enable establishing a probable diagnosis accord-
ing to DSM-IV-TR criteria (American Psychiatric Associa-
tion, 2000). Table 2 shows the YGTSS-ABBR questionnaire
used for measuring tics. A diagnosis of probable chronic tic
disorder was established if the person had: (1) one or more
chronic motor or one or more vocal tics, that (2) occurred
before age21, and (3)hadbeenpresent for>1year. Probable
TS diagnosis was established when two or more motor and
one or more vocal tics were reported that occurred before
age 21 and had lasted for >1 year, and probable transient
tic disorder was established when motor and/or vocal tics
had occurred before age 21 for less than one year. From
these categories, we derived a dichotomous variable on ab-
sence or presence of a probable tic disorder diagnosis —
chronic tic disorder, transient tic disorder or TS, as refer-
enced by the Tourette SyndromeClassification StudyGroup
(1993). An extensive genetic analysis on the heritability of
tic disorders has been performed (Zilha˜o et al., 2015). Since
smoking is known to have an effect on DNA methylation
(Lee & Pausova, 2013), we controlled for smoking status in
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TABLE 2
Yale Global Tic Severity Scale Abbreviated
Please indicate whether you have ever had any of the
following involuntary sudden nervous tics 0–1 years 1–5 years More than
1 (several answers possible): Never ago ago 5 years ago
a Eye movements: for example, blinking, rolling, squinting
b Nose movements: for example, nose twitching,
broadening nostrils
c Lip or mouth movements: for example, chewing, licking,
pouting
d Head shaking
e Shoulder or neck movements
f Arm or hand movements: for example, rapid
‘purposeless’ bending, stretching
g Squeaking or whistling noises
h Growling, throat clearing, coughing, sniffing
i ‘Purposeless’ cursing or utterance of rude or obscene
language
2 If you have suffered from any of the above tics:
a At what age did you first exhibit any of these
phenomena?
_____years (age)
b Have you ever suffered from these tics for more than a
year at a time?
___ No___ Yes
c How often did you have tics in the period that you
suffered from them most?
___not daily
___ daily, but tic-free for most of the day
___daily, but tic-free periods of 3 hours not uncommon
___daily, with tic-free periods of at most half an hour
the epigenome-wide association analysis. Smoking status
was assessed at the moment of blood draw by interview.
Infinium HumanMethylation450 BeadChip Data
DNA methylation was assessed with the Infinium Hu-
manMethylation450 BeadChipKit (Illumina, Inc.; Bibikova
et al., 2011). Genomic DNA (500ng) from whole blood was
bisulfite treated using the ZymoResearch EZ DNA Methy-
lation kit (Zymo Research Corp, Irvine, CA, USA) follow-
ing the standard protocol for Illumina 450K micro-arrays,
by the department of Molecular Epidemiology from the
Leiden University Medical Center (LUMC), The Nether-
lands. Subsequent steps (i.e., samplehybridization, staining,
scanning) were performed by the Erasmus Medical Center
micro-array facility, Rotterdam, the Netherlands. QC and
processing of the blood methylation dataset has been de-
scribed in detail previously (Van Dongen et al., 2015). In
short, a number of sample-level and probe-level quality
checks were performed. Sample-level QC was performed
usingMethylAid (van Iterson et al., 2014). Probeswere set to
missing in a sample if they had an intensity value of exactly
zero, or a detection p-value> .01, or a bead count< 3. After
these steps, probes that failed based on the above criteria in
>5% of the samples were excluded from all samples (only
probes with a success rate 95% were retained). Probes
were also excluded from all samples if they mapped to mul-
tiple locations in the genome (Chen et al., 2013), and/or
had a SNP within the CpG site (at the C or G position) irre-
spective of minor allele frequency in the Dutch population
(Genome of the Netherlands Consortium, 2014). Only au-
tosomal methylation sites were analyzed in the EWAS. The
methylation data were normalized with Functional Nor-
malization (Fortin et al., 2014) and normalized intensity
values were converted into beta ()-values. The -value
represents the methylation level at a site, ranging from 0 to
1 and is calculated as
 = M
M + U + 100 ,
where M = methylated signal, U = unmethylated signal,
and 100 represents a correction term to control the -value
of probes with very low overall signal intensity. After QC,
from an initial total of 485,577 methylation sites, the final
total selection of methylation sites was 411,169.
Statistical Analysis
EWAS was performed using linear regression under an ad-
ditive model correcting for principal components (PCs)
and covariates. PCs were calculated from the methylation
data after QC and normalization. The PCA plot calculated
can be seen in Supplementary Figure S2. Supplementary
Figure S3 provides the correlation plot between the first
20 PCs and the covariates (monocyte count, eosinophils
count, neutrophils count, array row number, smoking sta-
tus, age, and sex) in our dataset. Generalized estimation
equation (GEE) models were used to test whether tics were
associated with DNAmethylation. In the final model, DNA
methylation level was used as outcome with the following
predictors: tics, top five PCs, smoking status, eosinophil
percentage, and monocyte percentage. Additional models
were tested to evaluate the inflation factor with different co-
variates (Supplementary material). Sex, neutrophils count,
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FIGURE 1
(Colour online) Two-dimensional PCA plot labeled by case-control status.
and age were not included due to their correlation with
the top five PCs (Supplementary Figure S3). Basophil per-
centage was not included because it showed little variation
between subjects, with a large number of subjects having
0% of basophils. Smoking status was coded as ‘0 = non-
smoker’, ‘1 = former-smoker’, ‘2 = current-smoker’. GEE
uses cluster robust standard errors with family ID as clus-
ter variable, and thus standard errors are robust for the
presence of related individuals in the sample. A permuted
p-value was calculated by random sampling of the pheno-
type (n = 10,000), defining the proportion of permutations
meeting or exceeding our p-value estimate based on the
actual data. CpGs with p-values < 1.2 × 10−7 (Bonferroni
correction of 0.05/411169— autosomal sites) were consid-
ered statistically significant.
Enrichment of Gene Ontology Terms
Enrichment of GO terms among methylation sites having
a stronger association with tics was done by ranking all
methylation sites based on the EWAS p-value and the re-
sulting ranked gene list was supplied to the online software
tool GOrilla (Eden et al., 2009). The GO tool GOrilla takes
into account the rank of the gene whereby p-value cut-off is
not required in creating the gene list. A false discovery rate
(FDR) q-value <0.05 was considered for a GO term to be
statistically significant.
Results
After QC, the final dataset consisted of 411,169 autoso-
mal CpG sites, for 1,678 individuals (188 cases and 1,490
controls). The variation in the data captured by the first
two PCs is shown in Figure 1. It can be seen that the main
contributors to variation in DNA methylation are not as-
sociated with the phenotype. The first component repre-
sented sex and the second component correlated strongly
with neutrophil count. Supplementary Figure S1 shows the
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FIGURE 2
(Colour online) QQ plot of p-values from GEE model with top five PCs and covariates tics, smoking status, eosinophils, monocytes, and
array row.
distribution of genome-wide methylation level for all indi-
viduals included in the analysis.
The quantile-quantile (QQ) plot based on the EWAS
model is shown in Figure 2. The inflation factor () is
1.03, indicating that the results are not stratified.
None of the CpG sites passed the Bonferroni p-value
threshold (p = 1.2 × 10−7) for the association with Tics.
Table 3 shows all CpG sites with a p-value< 1× 10−4 (N =
57). Permutation tests for all of these 57CpGsites resulted in
a permutation p-value< .05, indicating that these CpG sites
did not occur by chance. As an example, the distribution
of permutation p-values for the top nine CpGs is shown in
Supplementary Figure S7. The Manhattan plot can be seen
in Figure 3 with the top 57 CpG sites highlighted in green.
Figure 4 shows the methylation level in cases and controls
for our top 15 CpGs.
Gene Ontology Enrichment Analysis
GO enrichment analysis identified a large number of GO
terms that were significantly enriched (Supplementary
Tables T1–T3). Top enriched GO Processes include devel-
opmental process (GO:0032502, p = 3.98e−16, FDR q-value
= 2.69e−12), cellular developmental process (GO:0048869,
p = 4.35e−16, FDR q-value = 1.96e−12), single-organism
developmental process (GO:0044767, p = 6.57e−23, FDR
q-value = 2.22e−12), and other GO terms related to de-
velopment. Brain processes, including regulation of neu-
ron projection guidance (GO:0097485, p = 8.33e−11, FDR
q-value = 5.11e−08), axon guidance (GO:0007411, p =
8.33e−11, FDR q-value = 4.89e−08), and neuron differ-
entiation (GO:0030182, p = 1.15e−10, FDR q-value =
6.24e−08) were also significantly enriched. The topmost en-
riched GO component was cell junction (GO:0030054, p =
6.73e−09, FDR q-value= 1.09e−05), followed by the neuron-
specific GO components neuron part (GO:0097458,
p = 4.39×10−07, FDR q-value = 1.78e−04), synapse part
(GO:0044456, p = 5.13×10−06, FDR q-value = 1.39e−03),
postsynaptic density (GO:0014069, p = 1.67e−05, FDR
q-value = 3.87e−03) and dendrite (GO:0030425, p =
1.04e−04, FDR q-value= 1.05e−02). GOcomponents related
to histone modification, including MOZ/MORF histone
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FIGURE 3
Manhattan plot showing the p-values of genome-wide CpG sites. The red line is the genome-wide threshold and the blue line is the
suggestive threshold (p < 1 × 10–4). Top CpG sites are highlighted in green.
FIGURE 4
Average methylation levels of the top CpGs in cases versus controls.
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TABLE 3
Top CpG Sites in the EWAS With p-value <0.0001
CpG Location [Nearest] Gene
CpG site CHR (bp) p-value  gene location
cg15583738 8 2176944 1.98e-06 0.00408 — —
cg06026425 5 157284650 2.03e-06 0.008678 CLINT1 5q33.3
cg01321816 15 91358514 2.32e-06 0.006536 BLM 15q26.1
cg03573179 6 36165382 4.07e-06 0.003791 BRPF3 6p21.31
cg20519670 14 65172006 6.91e-06 -0.00561 PLEKHG3 14q23.3
cg16463697 2 223886480 8.97e-06 0.006082 KCNE4 2q36.1
cg00785856 15 59041883 1.03e-05 0.005749 ADAM10 15q21.3
cg22033061 19 17531746 1.04e-05 0.003424 FAM125A/MVB12A 19p13.11
cg19830950 10 102729375 1.21e-05 0.002377 SEMA4G 10q24.31
cg08093277 6 29595299 1.31e-05 0.006787 GABBR1 6p22.1
cg12961733 22 50165244 2.17e-05 0.009437 BRD1 22q13.33
cg22430950 17 35166190 2.62e-05 -0.0146 — —
cg16208491 6 4021748 2.76e-05 0.003249 PRPF4B 6p25.2
cg14830166 12 11821908 3.01e-05 -0.01192 ETV6 12p13.2
cg23261919 10 135072960 3.20e-05 0.002744 ADAM8 10q26.3
cg08451325 21 44720984 3.25e-05 0.003124 SNF1LK/SIK1 21q22.3
cg15234400 4 174453166 3.29e-05 -0.01027 NBLA00301/HAND2-AS1 4q34.1
cg21923992 3 185825749 3.38e-05 0.007345 ETV5 3q27.2
cg07394446 15 100881458 3.39e-05 -0.00446 ADAMTS17 15q26.3
cg19391247 20 2360385 3.42e-05 0.00292 TGM6 20p13
cg07975472 19 1503610 3.44e-05 0.003127 ADAMTSL5 19p13.3
cg23572228 7 4923575 3.48e-05 0.006102 RADIL 7p22.1
cg25086136 8 50823124 3.56e-05 -0.00347 SNTG1 8q11.21
cg06872019 13 31588778 3.66e-05 -0.012 C13orf26/TEX26 13q12.3
cg20240091 1 175044916 3.69e-05 0.00516 TNN 1q25.1
cg17750334 1 214776613 3.96e-05 -0.00386 CENPF 1q41
cg14752139 8 7328654 3.96e-05 0.003239 DEFB104B 8p23.1
cg16650530 1 32538413 4.06e-05 0.002929 TMEM39B 1p35.2
cg23221732 17 72383708 4.14e-05 -0.00432 GPR142 17q25.1
cg03704355 12 102270112 4.15e-05 0.002634 DRAM/DRAM1 12q23.2
cg26548492 5 135170171 4.79e-05 -0.00723 LOC153328/ SLC25A48
cg21651356 12 104685539 5.27e-05 -0.01119 TXNRD1 12q23.3
cg11597832 14 105993747 5.39e-05 0.003214 TMEM121 14q32.33
cg19403269 1 5569798 5.57e-05 -0.01835 — —
cg24688563 1 160388964 5.77e-05 0.006028 VANGL2 1q23.2
cg18556420 10 864596 5.99e-05 -0.01245 LARP5/LARP4B 10p15.3
cg26116669 2 88654640 6.39e-05 0.007397 — —
cg01927730 6 168955764 6.56e-05 -0.00385 SMOC2 6q27
cg23066982 6 26204463 6.58e-05 0.002922 HIST1H4E 6p22.2
cg01490283 19 4066033 6.70e-05 0.003977 ZBTB7A 19p13.3
cg21879791 6 29594830 7.07e-05 0.003829 GABBR1 6p22.1
cg15347627 4 2941570 7.08e-05 0.004751 NOL14/NOP14 4p16.3
cg01703966 7 143207845 7.36e-05 -0.00416 LOC285965
cg19511664 3 135685098 7.53e-05 0.002758 PPP2R3A 3q22.2
cg11155621 17 43238118 7.60e-05 0.003843 HEXIM2 17q21.31
cg07477602 1 56961319 7.82e-05 0.002334 PPAP2B 1p32.2
cg00473985 16 87670568 7.94e-05 0.001967 JPH3 16q24.2
cg04747445 3 107241417 8.09e-05 0.004325 BBX 3q13.12
cg27135510 11 2423571 8.43e-05 0.001627 TSSC4 11p15.5
cg02525719 4 183728549 8.59e-05 0.01153 ODZ3/TENM3 4q34.3
cg19497750 14 70588881 8.63e-05 -0.00479 SLC8A3 14q24.2
cg22112443 15 37393989 8.66e-05 0.002057 MEIS2 15q14
cg21281009 18 14748298 8.79e-05 -0.01545 ANKRD30B 18p11.21
cg01119319 7 38356808 9.04e-05 0.014511 TARP 7p15-p14
cg24419101 17 6484720 9.17e-05 0.002819 KIAA0753/TXNDC17 17p13.1
cg25203007 1 24126017 9.22e-05 0.00304 GALE 1p36.11
cg08490349 17 17086207 9.92e-05 0.002258 M-RIP/MPRIP 17p11.2
Note: CHR = chromosome; , Difference in mean methylation -values between cases and controls; bp, base pairs.
acetyltransferase complex (GO:0070776, p = 4.21e−05, FDR
q-value = 6.20e−03) and H3 histone acetyltransferase com-
plex (GO:0070775, p = 4.21e−05, FDR q-value = 5.68e−03),
were significantly enriched. The top enriched GO function
was protein binding (GO:0005515, p = 1.10e−17, FDR q-
value = 4.55e−14) followed by many functions involving
DNA binding.
Discussion
In this work, we present the first genome-wide epigenetic
analysis on tics/tic disorders. Although no methylation site
achieved significance at the genome-wide threshold, gene-
ontology analysis of the top hits revealed enrichment in
brain-specific anddevelopmental processes. Thus, our find-
ings provide interesting targets for further analysis.
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Two of our top CpGs (cg08093277 and cg21879791,
ranked 11 and 41) are located near theGABBR1 gene (39670
bp and 39201 bp, at 5′, respectively), which represents a very
interesting target for further analysis. GABBR1 encodes a
subunit of the GABA receptor, the major inhibitory neu-
rotransmitter in the central nervous system (CNS). GABA
acts at brain inhibitory synapses where it binds transmem-
brane receptors of both presynaptic and postsynaptic neu-
rons. Notably, GABBR1 has been previously associated with
autism, schizophrenia, tremor, and obsessive-compulsive
disorder (Fatemi et al., 2009; Hegyi, 2013; Luo et al., 2012;
Richter et al., 2012).
The involvement of GABA in TS is well documented
in the extant neurobiological literature. Tics have been as-
sociated with reduced basal ganglia volume and reduced
cortical thickness in motor and sensorimotor areas con-
trolling the facial, orolingual, and laryngealmuscles (Sowell
et al., 2008). Studies of brain activity using PET or fMRI in
TS subjects compared to controls have implicated dysfunc-
tional striatum and thalamus, as well as cortical regions.
The medium-sized spiny neurons in the basal ganglia have
GABAergic inhibitory projections to the substantia nigra
and Globus Pallidus (Ribak et al., 1979). It is hypothesized
that the tonic activity of the striatum acts to inhibit un-
wanted motor patterns (Albin & Mink, 2006). Treatment
strategies have aimed at increasing GABA levels (Awaad,
1999; Mink, 2001) to counteract decreased inhibitory out-
put resulting in excessive activity in frontal cortical areas.
Although not all studies showed significant results, one
randomized double-blind study administering a GABA -
receptor agonist inTS resulted in reduced tic severity (Singer
et al., 2001).
Importantly, 8 of the top 57 associated CpG sites
(p < 1 × 10−4) mapped to genes that have been previ-
ously associated with psychiatric or neurological disorders,
some of them sharing neurodevelopmental aspects with tics
(OCD, autism, bipolar disorder, schizophrenia, some forms
of mental retardation), some disorders involving cortico-
striatal pathways similar to tics (as in the case of Parkin-
son’s disease), and some in which the link with tics seems
less clear (Alzheimer’s disease) (Supplementary Table T4
summarizes the genes from our top list that have been
previously associated with neurological disorders). CpG
site cg06026425, located near CLINT1, has been linked to
schizophrenia (Leon et al., 2011; Wang et al., 2010). More-
over, cg01321816, located near BLM, and cg00785856, lo-
cated near ADAM10, involve genes that have been associ-
ated with Alzheimer’s disease (Schro¨tter et al., 2013; Vassar,
2013). Another example is cg26548492, which is located
near LOC153328/SLC25A48, a gene that has been proposed
as candidate for Parkinson’s disease (Liu et al., 2011). Lastly,
cg2051967, which is located near PLEKHG3, involves a gene
that has been linked to mental retardation (Lehalle et al.,
2014; Lybaek et al., 2008). Furthermore, some of the top hits
lead to genes with a brain-specific function. This is the case
for cg25086136, located near SNTG1, which is specifically
expressed in the CNS (Hafner et al., 2010), and cg19830950,
located near SEMA4G, which might play a role in cere-
bellar development, the cerebellum being a core structure
involved in the precision of motor control (Maier et al.,
2011).
Histonemodificationmight alsoplay a role in the tic phe-
notype through the MOZ/MORF complex histone acetyl-
transferase complex (Klein et al., 2014). Genes involved
in histone modifications were significantly enriched in the
GO analysis. Acetylation represents one of the most fre-
quent post-translational modifications (PTM) and it is cat-
alyzed by lysine acetyl-transferase enzymes (KAT). It neu-
tralizes the positive charge present on the amino group of
histone tails, allowing the switch from a condensed struc-
ture to a more relaxed one, which results in an enhanced
level of transcription. Two of the top CpGs (cg03573179
in the BRPF3 gene and cg12961733 in the BRD1 gene) are
pointing to this MOZ/MORF complex, which is formed by
bromodomain PHD finger protein (BRPF1/2/3), inhibitor
of growth 5 (ING5), and homolog of Esa1-associated fac-
tor 6 (hEAE6) (Sapountzi & Cote, 2011). BRD1 is associ-
ated with schizophrenia and bipolar disorder (Christensen
et al., 2012) and the MOZ/MORF complex plays a role in
the regulation of the dentate gyrus, which is a brain struc-
ture extremely important for learning and memory (You
et al., 2015). BRD1, which is a component of the histone
H3 acetyltransferase activity within the MOZ/MORF com-
plex, might have a role in gene expression through acety-
lation of histone H3 and H4 (Doyon et al., 2006). BRD1
has also been associated with schizophrenia and bipolar
disorder (Christensen et al., 2012; Severinsen et al., 2006).
BRPF3 is another component of the histoneH3 acetyltrans-
ferase activitywithin theMOZ/MORF complex (Ullah et al.,
2008). CpG site cg23066982 is located near the HIST1H4E
gene, which is a member of the histone 4 family and is a
part of the nucleosome core. It is known that nucleosomes
pack DNA into chromatin to regulate several processes
such as transcription, DNA replication, and chromosome
stability.
These findings support a role for aberrant DNA methy-
lation levels in tic disorders as part of a broader neurode-
velopmental dysregulation. It is important to note that our
study examined DNA methylation in blood rather than in
the CNS. The relationship with DNA methylation in CNS
tissue remains unclear. However, it has been suggested that
inter-individual variation in DNAmethylation is correlated
to some extent across blood and brain tissues (Davies et al.,
2012). Also, it was observed that exposure to different forms
of early life traumas led to similar methylation changes in
blood and brain cells (Klengel et al., 2013). It has been pro-
posed that epigenetic changes induced early in development
in particular may be present across many different tissues,
because they are propagated through cell division (Feinberg
& Irizarry, 2010; Jeffries et al., 2012;Mill &Heijmans, 2013).
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Future studies might consider taking a trans-diagnostic
neurodevelopmental approach, combining tic disorders
and other neurodevelopmental disorders (including OCD,
autism, ADHD, and childhood movement disorders), to
disentangle common versus disorder-specific underlying
methylation patterns. Finally, environmental factors as-
sessed in a longitudinal studydesign shouldbe incorporated
in epigenetic studies, to investigate which environmental
stressors/protectors at what age/stage of development in-
fluence DNA methylation.
This study provides a first step to unravel the role of
epigenetic mechanisms in tic disorders. It should be noted
that we analyzed an ‘inclusive’ tic phenotype definition that
may obscure different underlying etiologies. Future studies
of larger size or including clinical samples at the more ex-
treme end of the tic phenotypic spectrum are required to
improve statistical power. Future studies should also aim
to examine different phenotypic tic dimensions (de Haan
et al., 2015). Such studies hold the promise to shed light
on the complex interaction between environmental and
genetic factors leading to development and persistence of
neuropsychiatric disorders.
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